Close
Help




JOURNAL

Substance Abuse: Research and Treatment

129,524 Journal Article Views | Journal Analytics

Epidemiologic and Molecular Pathophysiology of Chronic Opioid Dependence and the Place of Naltrexone Extended-Release Formulations in its Clinical Management

Submit a Paper



Publication Date: 27 Sep 2012

Type: Review

Journal: Substance Abuse: Research and Treatment

Citation: Substance Abuse: Research and Treatment 2012:6 115-133

doi: 10.4137/SART.S9031

Abstract

Naltrexone implants and depot injections (NI) are a novel form of treatment for opiate dependence (OD). Major questions relate to their absolute and relative efficacy and safety. Opportunely, six recent clinical trial data from several continents have uniformly provided dramatic evidence of the potent, dose-related and highly significant efficacy of NI, with minimal or manageable accompanying toxicity and safety concerns. The opiate-free lifestyle is attained significantly more often with NI adjusted O.R. = 6.00 (95% C.I. 3.86–9.50), P < 10-10. Other drug use and drug craving are also rapidly reduced. The optimum manner in which to commence NI remains to be established. Of particular relevance is the relative safety of NI compared to the chronic opiate agonists (COA) usually employed, as the long-term toxicity of COA is only just being elucidated. Large population-based studies have found elevated rates of cardiovascular disease, six cancers, liver and respiratory disease, and all-cause mortality in COA. Whilst opiates have been shown to trigger numerous molecular pathways, the most interesting is the demonstration that the opiate morphinan's nucleus binds to the endotoxin groove of the TLR4-MD2 heterodimer. This has the effect of triggering a low grade endotoxaemic-like state, which over time may account for these protean clinical findings, an effect which is reversed by opiate antagonists. This emerging evidence suggests an exciting new treatment paradigm for OD and a corresponding increase in the role of NI in treatment.


Downloads

PDF  (568.80 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML






What Your Colleagues Say About Substance Abuse: Research and Treatment
Each promise from the team at Substance Abuse: Research and Treatment has been backed up by action.  Well organized team, prompt cycle times throughout the process of article submission, review, acceptance and article proofs.  You guys have been fantastic.  No wonder you've garnered such a good reputation in such a short time.
Dr Bawo O. James (Department of Clinical Services, Federal Neuro Psychiatric Hospital, Benin City, Edo State, Nigeria)
More Testimonials

Quick Links


New article and journal news notification services